GEN-MKT-18-7897-A
Jan 24, 2017 | Biopharma, Blogs | 0 comments
Have you ever wished for a compact instrument that delivers expert-level answers to your most complex biotherapeutic characterization challenges faster and easier than what you are doing now? At SCIEX, we recognize that even expert users want easier ways to perform daily characterization tasks and get great results every time. That’s why we set out to develop the X500B QTOF system: a robust and reliable new instrument and software solution that reduces complexity and simplifies biologics characterization workflows so every scientist can get expert-level results.Download Info Pack >
Flexible and Robust: The X500B QTOF Makes Standard Characterization Workflows a Breeze
The new X500B QTOF system is the first true benchtop, high-resolution mass spectrometer designed specifically for characterization of complex biologics, delivering high-quality data for intact mass and peptide mapping analyses–including post-translational modification identification–and characterization of antibody-drug conjugates. The system utilizes the renowned SCIEX Turbo V™ ionization source and a heated TOF path for maximum robustness and reproducibility. Add to that the new SCIEX OS Operating System and BioPharmaView™ data processing software, which are surprisingly easy to learn and operate.
The new X500B system enables you to:
As a part of the SCIEX 360º Innovation for Biologics Characterization strategy, the X500B QTOF system is designed to help you get better answers, faster. For standard biologics characterization workflows, the compact X500B system is the next “big” thing to improve your lab’s productivity and throughput.
Download your free information pack showing how simple it is to set up your biologics characterization, including:
Regulated laboratories are evolving faster than ever. New analytical modalities, higher sample throughput, increasing regulatory scrutiny, and leaner teams are reshaping how work gets done. At the same time, expectations for data integrity, standardization, and operational efficiency continue to increase complexity and/or scope. In this environment, LC-MS software is no longer simply an instrument control platform—it has become a critical part of a laboratory’s quality management system. The question is no longer whether your lab has changed, but whether your software has evolved to support the way regulated labs operate today, and if they are ready and able to meet the demands, they will face tomorrow.
Analyst software has long been a trusted foundation in regulated LC-MS laboratories—and for many, it still performs reliably today. But regulated environments are evolving faster than ever. As labs transition to Windows 11, strengthen cybersecurity policies, modernize IT infrastructure, and prepare for future compliance expectations, software decisions are no longer just about what works today—they’re about managing tomorrow’s risk. Analyst will not be supported on Windows 11. While some labs may continue operating in unsupported environments temporarily, the bigger question is: when that risk becomes reality, will your lab be reacting under pressure—or executing a planned mitigation strategy with confidence?
As regulatory scrutiny increases and detection requirements tighten, laboratories are facing a new question: How can TFA be measured reliably, sensitively, and at scale?
Posted by
You must be logged in to post a comment.
Share this post with your network